MART-1 (26-35) (human) TFA

MART-1 (26-35) (human) TFA, an epitope peptide, is indispensably employed in the realm of biomedical research aimed at immunotherapy advancements. Proficiently directed at melanoma antigens, it exerts an influential impact on inciting the immune system's response against the malignant melanoma cells, thus exhibiting its paramount significance in fostering groundbreaking therapeutic interventions tailored for afflicted melanoma subjects.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	GR2200
M.F/Formula	C44H75F3N10O16
M.W/Mr.	1057.12
Appearance	Solid

CAT#	Product Name	Inquiry
GR2145	PBP10 TFA	Inquiry
GR2193	TAT-GluA2 3Y	Inquiry
GR2151	D-JNKI-1	Inquiry
GR2143	Angiopep-2 hydrochloride	Inquiry
GR2177	Pep-1-Cysteamine	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.